Table 1.

Randomized Controlled Trials Comparing Outcomes in Patients With Acute Pancreatitis Receiving EN vs PN That Included IV Lipids.

Author (Year)	IV Lipid Brand (Conc.), Target Dose/24 h	No. of Deaths/Organ Failure/Patients
		EN Group	IV Lipid Group
Wu et al3 (2010)	Intralipid (20%), 250 mL	6/11/53	23/44/54
Eckerwall et al24 (2006)	Kabiven (?), 25 kcal/kg	1/1/24	0/1/26
Petrov et al6 (2006)	? (10%), 30 kcal/kg	2/11/35	12/27/34
Louie et al4 (2005)	Intralipid (10%), 25 kcal/kg	0/7/10	3/13/18
Gupta et al8 (2003)	? (10%), 500 mL	0/0/8	0/6/9
Olah et al7 (2002)	Intralipid (10%), 30 kcal/kg	2/2/41	4/5/48
Kalfarentzos et al5 (1997)	Lipofudin (20%), 30–35 kcal/kg	1/2/18	2/4/20

The second column mentions the brand of intravenous (IV) lipid used in the study, the concentration (Conc.) of the lipid emulsion, and the method of dose calculation described in the study (ie, volume of the IV lipid in milliliters/24 hours or target total kcal/kg/24 hours, including those from other sources). The 2 columns on the right mention the outcomes in each group as the number of deaths/number of patients with organ failure/total number of patients in the group. The “?” indicates that the information was not specified.

EN, enteral nutrition; PN, parenteral nutrition.